TFE3 and neoplasm: investigated almost 1500 tumors of 64 histologic tumor types from 16 sites and found TFE3 nuclear immunoreactivity to be restricted to alveolar soft part sarcoma (19/19 cases) and some distinct types of renal cell carcinoma (20/21 cases).